Connection
Maryam Asgari to Rituximab
This is a "connection" page, showing publications Maryam Asgari has written about Rituximab.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.191 |
|
|
|
-
Pahalyants V, Murphy WS, Klebanov N, Lu C, Theodosakis N, Klevens MR, Estiri H, Lilly E, Asgari M, Semenov YR. Reply to: "COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated". J Am Acad Dermatol. 2022 07; 87(1):e47-e48.
Score: 0.191